Kuvi.ai Launches Private Beta of Agentic Finance OS with Seed Round Led by Moon Pursuit Capital, with Additional Support from Transform Ventures and VirtualBacon
Toronto, Canada, July 29, 2025 (GLOBE NEWSWIRE) — Kuvi.ai , the platform pioneering Agentic Finance, has announced the successful completion of its $700,000 seed round, led by Moon Pursuit Capital, and the expansion of its strategic round, which is now oversubscribed. Recent additions include legendary crypto investor Michael Terpin of Transform Ventures and leading Web3 educator Dennis Liu (aka VirtualBacon).
The announcement follows Kuvi.ai's earlier pre-seed (angel) round, which closed in just four days. With the close of the seed round and the opening of the strategic round, Kuvi.ai's valuation has now doubled from $15 million to $30 million.
The funding supports the private beta launch of Kuvi.ai's Agentic Finance Operating System (AF-OS), the first of its kind next-gen interface that empowers users to design, automate, and deploy complex financial strategies using natural language.
Kuvi.ai replaces the need for centralized exchanges, clunky DeFi dashboards, or opaque robo-advisors, enabling users to act with precision, automation, and control. Kuvi.ai is an AI-driven crypto interface designed to make digital asset transactions as simple as typing a message or saying a few words, delivering text-to-trade functionality that removes the need to navigate multiple dApps, bridging solutions, or complex trading interfaces.
Users can instruct Kuvi.ai to buy, sell, or swap tokens across blockchains, and Kuvi.ai does the rest. Unlike pre-programmed bots or chat wrappers, Kuvi.ai allows users to define their financial intent — e.g., 'Buy $1K in memecoins when sentiment spikes and gas is low, exit when BTC dominance rises' — and executes via our proprietary modular and functional agentic framework.
'Kuvi.ai is building the coordination layer for agentic value transfer,' said co-founder and CEO Dylan Dewdney.
Kuv.ai's private beta, rolling out now to early community, investors, supporters, collaborators, and some OTC desks, introduces smart 'Executables.' These are automations tied to market conditions, cross-chain actions, and real-time data. Early integrations include top Solana-native protocols like Raydium and Jupiter, with Ethereum and Bitcoin native protocols soon to follow.
'This is not just a new product,' added co-founder and CTO Jay Nasr. 'It's a complete rethink of how humans interact with financial systems.'
With private beta underway and TGE tentatively slated for late summer/early fall 2025, Kuvi.ai is set to scale its user base, integrations, and community. As the Agentic Finance movement gains traction, Kuvi.ai is positioned to be the flagship OS in a post-app financial world — empowering everyone to manage and multiply wealth through intent-based interfaces.
Please follow Kuvi.AI X: @kuvilabsTelegram: @kuviai
Discord: https://discord.com/invite/r5Hfpk5BPa
Instagram: https://www.instagram.com/kuviai
About Kuvi.ai
Kuvi.ai is an AI-driven crypto interface designed to make digital asset transactions as simple as typing a message or saying a few words, delivering text-to-trade functionality that removes the need to navigate multiple dApps, bridging solutions, or complex trading interfaces. Users can instruct Kuvi.ai to buy, sell, or swap tokens across blockchains, and Kuvi.ai does the rest.
Kuvi.ai is founded by Dylan Dewdney, a crypto OG active since 2011, along with Jay Nasr, and Maxim Sindall, bringing technical depth and go-to-market execution. Kuvi.ai's momentum is powered by a heavyweight advisory and investor roster that includes Michael Terpin, founder of Transform Ventures and early advisor/investor to hundreds of crypto projects, including Ethereum and Tether; Dennis Liu (VirtualBacon), top-tier crypto educator with 400K+ followers; and Peter Vincer, advisor with institutional and U.S. policy access, joins as Advisor for Government Relations. For more information, please visit https://kuvi.ai.
Media contact: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
2 hours ago
- Hamilton Spectator
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to six new non-officer employees consisting of an aggregate of 24,200 share options. All of the foregoing share options were approved by the Compensation Committee of the Company's Board of Directors with an effective date of July 31, 2025 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The share options have an exercise price of $30.54 per common share, which is equal to the closing price per share of Xenon's common shares on the grant date of July 31, 2025. The share option grants vest over four years, with 25% vesting on the one-year anniversary of the respective employee's start date and 1/36th of the remaining options vesting monthly thereafter on the last day of each month, subject to such option recipient's continued service relationship with the Company. Each option has a 10-year term and is subject to the terms and conditions of the share option agreement and the terms of the Company's 2025 Inducement Equity Incentive Plan. About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. For more information, please visit . 'Xenon' and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner. Contacts: For Investors: Chad Fugere Vice President, Investor Relations (857) 675-7275 investors@ For Media: Colleen Alabiso Senior Vice President, Corporate Affairs (617) 671-9238 media@
Hamilton Spectator
2 hours ago
- Hamilton Spectator
Lumine Group Inc. Announces Results for the Three and Six Months Ended June 30, 2025
TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Lumine Group Inc. ('Lumine Group' or 'the Company') (TSXV:LMN) announces financial results for the three and six months ended June 30, 2025. All amounts referred to in this press release are in US dollars unless otherwise stated. The following press release should be read in conjunction with the Company's unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2025, and management's discussion and analysis ('MD&A') for the three and six months ended June 30, 2025, which can be found on SEDAR+ at . Additional information about Lumine Group is also available on SEDAR+ and on Lumine Group's website . Q2 2025 Headlines: Year-to-Date Q2 2025 Headlines: Total revenue for the three months ended June 30, 2025 is $184.0 million, an increase of 13% or $21.1 million, compared to $162.8 million for the same period in 2024. For the six months ended June 30, 2025, total revenue was $362.6 million, an increase of 19%, or $58.7 million, compared to $303.9 million for the same period in 2024. The increase for the three and six months compared to the same period in the prior year is attributable to revenues from new acquisitions. The Company experienced organic growth of 9% and 2%, respectively, for the three and six months ended June 30, 2025, or 6% and 1% after adjusting for the impact of changes in the valuation of the US dollar against most major currencies in which the Company transacts business. For acquired companies, organic growth is calculated as the difference between actual revenues achieved by each business in the financial period following acquisition, compared to the estimated revenues they achieved in the corresponding financial period preceding the date of acquisition by the Company. Organic growth is not a standardized financial measure and might not be comparable to measures disclosed by other issuers. Operating income for the three months ended June 30, 2025 was $62.7 million, an increase of 71%, or $26.1 million, compared to $36.6 million for the same period in 2024. Operating income for the six months ended June 30, 2025 was $122.2 million, an increase of 51%, or $41.1 million, compared to $81.1 million for the same period in 2024. The increase for the three and six month periods is primarily attributable to growth from acquisitions. Operating income is not a standardized financial measure and might not be comparable to measures disclosed by other issuers. See 'Non-IFRS Measures'. Net income for the three months ended June 30, 2025 was $23.6 million compared to net loss of $2.2 million for the same period in 2024. Net income for the six months ended June 30, 2025 was $44.3 million compared to net loss of $306.6 million for the same period in 2024. The increase in net income for the three and six months is primarily attributable to growth from acquisitions and the Mandatory Conversion of Preferred and Special Securities on March 25, 2024 such that no further preferred and special securities expense was booked in the subsequent quarters. For the three months ended June 30, 2025, CFO increased $68.7 million to $78.4 million compared to $9.7 million for the same period in 2024 representing an increase of 705%. For the six months ended June 30, 2025, CFO increased $73.8 million to $118.5 million compared to $44.7 million for the same period in 2024 representing an increase of 165%. The primary reason for the increase is that CFO includes the impact of changes in non-cash operating assets and liabilities exclusive of effects of business combinations or changes in non-cash operating working capital ('NCOWC') which improved during the three and six months ended June 30, 2025 compared to the same period prior year, as well as higher operating income. For the three months ended June 30, 2025, FCFA2S increased $69.6 million to $72.4 million compared to $2.8 million for the same period in 2024. For the six months ended June 30, 2025, FCFA2S increased $75.8 million to $107.4 million compared to $31.5 million for the same period in 2024. The increase in the three and six months ended June 30, 2025 is driven by higher CFO compared to the same periods in 2024. FCFA2S is a non-IFRS Measure. See 'Non-IFRS Measures'. Non-IFRS Measures Operating income (loss) refers to income (loss) before income taxes, amortization of intangible assets, redeemable Preferred and Special Share expense, gain on bargain purchase, and finance and other expenses (income). We believe that operating income is useful supplemental information as it provides an indication of the profitability of the Company related to its core operations. Operating income (loss) is not a recognized measure under IFRS and may not be comparable to similar financial measures disclosed by other issuers. Accordingly, readers are cautioned that operating income (loss) should not be construed as an alternative to net income (loss). The following table reconciles operating income to net income: Free cash flow available to shareholders ''FCFA2S'' refers to net cash flows from operating activities less interest paid on lease obligations, interest paid on bank debt, transaction costs on bank debt, repayments of lease obligations, interest, dividends and other proceeds received, and property and equipment purchased net of proceeds from disposal. The Company believes that FCFA2S is useful supplemental information as it provides an indication of the uncommitted cash flow that is available to shareholders if Lumine Group does not make any acquisitions, or investments, and does not repay any debts. While the Company could use the FCFA2S to pay dividends or repurchase shares, the Company's objective is to invest all of its FCFA2S in acquisitions which meet the Company's hurdle rate. FCFA2S is not a recognized measure under IFRS and may not be comparable to similar financial measures disclosed by other issuers. Accordingly, readers are cautioned that FCFA2S should not be construed as an alternative to net cash flows from operating activities. The following table reconciles FCFA2S to net cash flows from operating activities: Forward Looking Statements Certain statements herein may be 'forward looking' statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Lumine Group or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward looking statements. These forward looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and Lumine Group assumes no obligation, except as required by law, to update any forward looking statements to reflect new events or circumstances. About Lumine Group Inc. Lumine Group acquires, strengthens, and grows, vertical market software businesses in the communications and media industry. Learn more at . For further information: David Nyland Chief Executive Officer Lumine Group investors@ +1-437-353-4910 Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Condensed Consolidated Interim Statements of Financial Position (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Income (Loss) (In thousands of USD, except per share amounts. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Comprehensive Income (Loss) (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statement of Changes in Equity (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statement of Changes in Equity (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Cash Flows (In thousands of USD. Due to rounding, numbers presented may not foot.) 1 See 'Non-IFRS Measures'.
Yahoo
3 hours ago
- Yahoo
1 Top Cryptocurrency That Can Overtake Ethereum by 2028, According to Standard Chartered Analyst Geoff Kendrick
Key Points Ethereum is viewed by many as the main blockchain for smart contracts and decentralized applications. Ethereum is also a network being used to tap into the potential of cryptocurrencies in the traditional payments industry. The two largest stablecoin companies issue their tokens on Ethereum's network, but will it be enough to stave off the competition? 10 stocks we like better than XRP › Since the crypto sector sprang to life right around the depths of the Great Recession, Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) have always operated as the one and two seeds -- Batman and Robin if you will. Bitcoin is the original cryptocurrency viewed as the bellwether of the industry. In recent years, many have begun to view Bitcoin and its finite 21 million tokens as a form of digital gold that can hedge inflation and serve as safe asset amid geopolitical uncertainty and the U.S. government's mounting debt situation. Ethereum, on the other hand, is viewed as the network that is the epicenter of smart contracts and decentralized applications. While Bitcoin's dominance doesn't look to be going anywhere, with a $2.3 trillion market cap, Standard Chartered analyst Geoff Kendrick thinks Ethereum could be vulnerable, with one top cryptocurrency set to flip Ethereum by 2028. The crypto story of the year Ethereum and Bitcoin have had strong years, particularly Bitcoin, which seems to become more ingrained in the mainstream financial world every day. But neither can come close to the year that XRP (CRYPTO: XRP) is having, up roughly 400% during the past year (as of July 31). Donald Trump's presidential election win back in November triggered a series of positive events for XRP, notably a change in leadership at the Securities and Exchange Commission (SEC). Once the Trump administration took office, the SEC quickly began settling or dropping major lawsuits including one against Ripple, the company behind XRP, which had been an overhang on the token for several years. Now, Kendrick thinks the run for XRP may have only just begun and that it's even possible that XRP overtakes Ethereum by 2028. As of this writing, Ethereum had a $460 billion market cap, while XRP had a $186 billion market cap. Kendrick's argument is built on the belief that XRP and Ripple will gain wider institutional adoption and begin to take share of cross-border payments market. Earlier this year, Ripple paid $1.25 billion to acquire the prime broker Hidden Road. Hidden Road offers institutional traders a wide range of services including clearing, prime brokerage, and funding for foreign exchange (FX), digital assets, derivatives, swaps, and fixed income. Ripple sees this as a way to continue to bridge the gap between institutional investors, digital assets, and payments. Earlier this year, Ripple Chief Executive Officer Brad Garlinghouse called out SWIFT's high cross-border transaction error rates, ranging from 6% to 11%. SWIFT, or the Society for Worldwide Interbank Financial Telecommunication, is used by banks all over the world to send payment instructions to one another, largely for the purpose of cross-border payments. Garlinghouse said he thinks Ripple and XRP could free up as much as $10 trillion in transfers through its near instant-settlement capabilities. The XRP network currently is capable of processing 1,500 transactions per second. Additionally, Garlinghouse believes XRP has the potential to take 14% of SWIFT's volume by 2030. Kendrick has a $5.50 price target on XRP by the end of this year, then $8 by 2026, and $12.50 by 2028. A $12.50 price would propel XRP's market cap to about $740 billion. XRP recently traded at about $3.10. Can XRP overtake Ethereum? Given the volatility in cryptocurrencies, I would always recommend that investors take crypto price targets with a grain of salt. Nobody can say for certain what will happen. However, cryptocurrencies with strong technical networks and use cases probably are the ones that will experience the most price appreciation. I find XRP and Ripple to be an intriguing story, and cross-border payments definitely seems to be a key area ripe for disruption by cryptocurrencies. While Ethereum is quite different from XRP, many stablecoins including the two largest U.S.-dollar backed stablecoins are issued on Ethereum's network, so it stands to benefit as well from increasing stabelcoin use. Although it's hard to say one way or another, I find it unlikely that XRP will overtake Ethereum in just a few years, primarily because Ethereum should benefit from cryptocurrencies and stablecoins taking payments volume. Ultimately, I find both Ethereum and XRP to be interesting cryptocurrencies with strong networks, so I do think investors can buy both. However, XRP has been more volatile, so I've been advising a smaller, more speculative position for now. Do the experts think XRP is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did XRP make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,049% vs. just 182% for the S&P — that is beating the market by 867.25%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $638,629!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,098,838!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Bram Berkowitz has positions in Bitcoin, Ethereum, and XRP. The Motley Fool has positions in and recommends Bitcoin, Ethereum, and XRP. The Motley Fool recommends Standard Chartered Plc. The Motley Fool has a disclosure policy. 1 Top Cryptocurrency That Can Overtake Ethereum by 2028, According to Standard Chartered Analyst Geoff Kendrick was originally published by The Motley Fool Sign in to access your portfolio
